CVS Health Corporation
MX ˙ BMV ˙ US1266501006
SecurityMX:CVS / CVS Health Corporation
InstitutionGreatmark Investment Partners, Inc.
Latest Disclosed Ownership115,659 shares
Latest Disclosed Value $ 8,306,629
Greatmark Investment Partners, Inc. reports 1.74% decrease in ownership of CVS / CVS Health Corporation

On April 28, 2026 - Greatmark Investment Partners, Inc. filed a 13F-HR form disclosing ownership of 115,659 shares of CVS Health Corporation (MX:CVS) valued at $8,306,629 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 117,711 shares of CVS Health Corporation. This represents a change in shares of -1.74% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F CVS HEALTH CORP COM Stock 126650100 115,659 -2,052 -1.74 8,307 -11.08 0.9731
2026-01-27 2025-12-31 13F CVS HEALTH CORP COM Stock 126650100 117,711 -4,080 -3.35 9,342 1.74 1.1049
2025-10-31 2025-09-30 13F CVS HEALTH CORP COM Stock 126650100 121,791 -3,070 -2.46 9,182 6.61 1.1008
2025-07-30 2025-06-30 13F CVS HEALTH CORP COM Stock 126650100 124,861 -1,642 -1.30 8,613 0.49 1.0812
2025-05-01 2025-03-31 13F CVS HEALTH CORP COM Stock 126650100 126,503 -1,760 -1.37 8,571 48.86 1.1686
2025-02-10 2024-12-31 13F CVS HEALTH CORP COM Stock 126650100 128,263 -178,639 -58.21 5,758 -70.17 0.7840
2024-10-31 2024-09-30 13F CVS HEALTH CORP COM Stock 126650100 306,902 11,072 3.74 19,298 10.45 2.6167
2024-08-08 2024-06-30 13F CVS HEALTH CORP COM Stock 126650100 295,830 22,703 8.31 17,472 -19.80 2.5484
2024-05-09 2024-03-31 13F CVS HEALTH CORP COM Stock 126650100 273,127 11,999 4.60 21,785 5.66 3.0958
2024-02-05 2023-12-31 13F CVS HEALTH CORP COM Stock 126650100 261,128 9,868 3.93 20,619 17.54 3.2311
2023-11-08 2023-09-30 13F CVS HEALTH CORP COM Stock 126650100 251,260 12,750 5.35 17,543 6.39 3.1022
2023-08-02 2023-06-30 13F CVS HEALTH CORP COM Stock 126650100 238,510 24,724 11.56 16,488 3.79 2.7756
2023-04-28 2023-03-31 13F CVS HEALTH CORP COM Stock 126650100 213,786 5,099 2.44 15,886 -18.31 2.8323
2023-01-30 2022-12-31 13F CVS HEALTH CORP COM Stock 126650100 208,687 -4,984 -2.33 19,448 -4.57 3.5564
2022-11-08 2022-09-30 13F CVS HEALTH CORP COM Stock 126650100 213,671 1,681 0.79 20,378 3.74 3.9331
2022-07-28 2022-06-30 13F CVS HEALTH CORP COM Stock 126650100 211,990 2,904 1.39 19,643 -7.18 3.7703
2022-04-27 2022-03-31 13F CVS HEALTH CORP COM Stock 126650100 209,086 -915 -0.44 21,162 -2.32 3.4790
2022-02-03 2021-12-31 13F CVS HEALTH CORP COM Stock 126650100 210,001 -149 -0.07 21,664 21.48 3.6376
2021-11-02 2021-09-30 13F CVS HEALTH CORP COM Stock 126650100 210,150 2,487 1.20 17,833 2.92 3.3399
2021-08-23 2021-06-30 13F CVS HEALTH CORP COM Stock 126650100 207,663 2,416 1.18 17,327 12.21 3.1342
2021-05-04 2021-03-31 13F CVS HEALTH CORP COM Stock 126650100 205,247 -418 -0.20 15,441 9.92 3.0168
2021-02-08 2020-12-31 13F CVS HEALTH CORP COM Stock 126650100 205,665 -1,244 -0.60 14,047 16.25 3.0396
2020-10-28 2020-09-30 13F CVS HEALTH CORP COM Stock 126650100 206,909 6,921 3.46 12,083 -7.00 3.0366
2020-08-04 2020-06-30 13F CVS HEALTH CORP COM Stock 126650100 199,988 -2,024 -1.00 12,993 8.41 3.4229
2020-04-29 2020-03-31 13F CVS HEALTH CORP COM Stock 126650100 202,012 3,145 1.58 11,985 -18.88 3.8510
2020-01-31 2019-12-31 13F CVS HEALTH CORP COM Stock 126650100 198,867 5,391 2.79 14,774 21.07 3.6487
2019-10-30 2019-09-30 13F CVS HEALTH CORP COM Stock 126650100 193,476 9,571 5.20 12,203 21.77 3.3412
2019-08-05 2019-06-30 13F CVS HEALTH CORP COM Stock 126650100 183,905 45,890 33.25 10,021 34.64 2.9921
2019-05-07 2019-03-31 13F CVS HEALTH CORP COM Stock 126650100 138,015 20,940 17.89 7,443 -2.97 2.3477
2019-02-01 2018-12-31 13F CVS HEALTH CORP COM Stock 126650100 117,075 39,475 50.87 7,671 25.57 2.7485
2018-10-31 2018-09-30 13F CVS HEALTH CORP COM Stock 126650100 77,600 7,480 10.67 6,109 35.39 1.9236
2018-08-03 2018-06-30 13F CVS Health COM 126650100 70,120 42,735 156.05 4,512 164.79 1.5574
2018-05-04 2018-03-31 13F CVS HEALTH CORP COM Stock 126650100 27,385 27,385 1,704 0.6209
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.